Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

From "Alternate Endings": A woman places a flower into Barbara Jean's green burial grave. Photo: Courtesy of HBO

Our friends Perri Peltz and Matthew O’Neill, the directors and producers of "Axios on HBO," have spent 2 years and traveled to 10 states to produce a landmark documentary on death and dying, "Alternate Endings: Six New Ways to Die in America." It premieres this Wednesday, Aug. 14, at 8pm ET on HBO.

What they're saying: Here's a bit of a long conversation I had with Peltz and O'Neill, who repeatedly hopped on planes over the past 2 years when they heard one of their subjects wasn't doing well.

Your subjects were really talkative. Some of them were even funny.

  • O’Neill: "The humor is because there's a great deal of comfort and affection in each of these stories. If there's one thing in each of these stories besides death, it's love. And out of that love comes humor and comes teasing and intimacy and smiles."

Why do we have so much trouble talking about death?

  • O’Neill: "The baby boomer generation has had a greater degree of control over their lives than any other generation before them. It's because every topic that's taboo — be it sex, be it drugs — it's all on television and it's all being talked about. And death is the last taboo."
  • Peltz: "As Axios would say, why does it matter? We both believe that if this film can at least begin a conversation about death, that's going to take us to a better and more informed place."

When you screened a segment at the Aspen Ideas Festival, people cried.

  • O'Neill: "What we've been hearing is some variation of 'I was nervous about watching this. I was afraid to watch this, but since watching it, I can't stop talking about it. I talk to my husband about it. I talk to my kids about it. It made me have a conversation with my kids here that I've been putting off.'"

How did making this documentary change you? 

  • Peltz: "My mother has been trying to talk to me about her end of life for a good 10 years now. And every time she says, 'We really should talk about the end and what's going to happen and about my will,' I basically put my fingers in my ears and say: 'No, no, no, no, no — another time.' And what I've learned from this film is we have to talk about it. I went back to my mother and I said: 'You're right. Let's talk about it.' And that, for me, was a big difference. I'm still afraid of dying. But I'm willing now to have a conversation about it."

🎬 Watch a clip.

Go deeper:

Subscribe to Axios AM/PM for a daily rundown of what's new and why it matters, directly from Mike Allen.
Please enter a valid email.
Please enter a valid email.
Server error. Please try a different email.
Subscribed! Look for Axios AM and PM in your inbox tomorrow or read the latest Axios AM now.

Go deeper

Biden explains justification for Syria strike in letter to Congress

Photo: Chris Kleponis/CNP/Bloomberg via Getty Images

President Biden told congressional leadership in a letter Saturday that this week's airstrike against facilities in Syria linked to Iranian-backed militia groups was consistent with the U.S. right to self-defense.

Why it matters: Some Democrats, including Sens. Tim Kaine (D-Va.) and Chris Murphy (D-Conn.) and Rep. Ro Khanna (D-Calif.), have criticized the Biden administration for the strike and demanded a briefing.

8 hours ago - Health

FDA authorizes Johnson & Johnson's one-shot COVID-19 vaccine for emergency use

Photo: Illustration by Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration on Saturday issued an emergency use authorization for Johnson & Johnson's one-shot coronavirus vaccine.

Why it matters: The authorization of a third coronavirus vaccine in the U.S. will help speed up the vaccine rollout across the country, especially since the J&J shot only requires one dose as opposed to Moderna and Pfizer-BioNTech's two-shot vaccines.

Updated 8 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios